Physician

Joy B Chastain, M.D.

According to 2025 Medicare claims, Joy Chastain, M.D. (NPI: 1396749925) practices dermatology in the Athens-Clarke County, GA market, with the plurality of this provider's patient population coming from Clarke, GA. This provider's primary affiliated billing organization is JOY B CHASTAIN MD PC (NPI: 1588720387; TIN: 200576430) and primary practice location at 30606-2190.

Chastain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 743 traditional Medicare patients, billed 48,419 HCPCS/CPT codes, and received $305,442 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 1,781 prescription claims across 565 beneficiaries totaling $545,994 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 76 records totaling $1,392. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$179K$359K2015 Medicare payment: $306,567 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $312,933 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $309,670 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $355,349 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $358,717 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $296,675 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $324,533 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $298,682 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $288,422 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $305,442 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1249,014$306,567
20161,1979,131$312,933
20171,2619,690$309,670
20181,3049,740$355,349
20191,33910,679$358,717
20201,0839,664$296,675
20211,03136,734$324,533
202270544,651$298,682
202378242,708$288,422
202474348,419$305,442

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$379K$758K2015 Drug cost: $377,133 (USD; Tot_Drug_Cst)2016 Drug cost: $474,667 (USD; Tot_Drug_Cst)2017 Drug cost: $569,304 (USD; Tot_Drug_Cst)2018 Drug cost: $610,232 (USD; Tot_Drug_Cst)2019 Drug cost: $687,353 (USD; Tot_Drug_Cst)2020 Drug cost: $757,790 (USD; Tot_Drug_Cst)2021 Drug cost: $420,795 (USD; Tot_Drug_Cst)2022 Drug cost: $462,496 (USD; Tot_Drug_Cst)2023 Drug cost: $568,702 (USD; Tot_Drug_Cst)2024 Drug cost: $545,994 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154951,587$377,133
20164911,592$474,667
20175161,671$569,304
20185931,916$610,232
20196141,940$687,353
20205561,919$757,790
20215271,676$420,795
20224731,655$462,496
20235031,654$568,702
20245651,781$545,994

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17004Destruction of precancer skin growth, 15 or more growths255367$112
17110Destruction of skin growth, 1-14 growths363432$77
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more549793$56
17000Destruction of precancer skin growth, 1 growth464610$31
17003Destruction of precancer skin growth, 2-14 growths4142,899$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab15420$101,763
OtezlaApremilast18540$86,288
Dupixent PenDupilumab15420$55,907
FluorouracilFluorouracil1123,340$7,972
Clobetasol PropionateClobetasol Propionate1484,165$4,946

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.76$1,392PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joy B. Chastain, M.D.?

Tedicare shows public-source Medicare data for Joy B. Chastain, M.D. (NPI 1396749925), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joy B. Chastain, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joy B. Chastain, M.D.?

Joy B. Chastain, M.D. is linked to JOY B CHASTAIN MD PC (billing NPI 1588720387) in the available physician profile data.

Does Joy B. Chastain, M.D. have Open Payments data?

Joy B. Chastain, M.D. has 76 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.